An additional $7m for manufacturing puts them probably around $8m for manufacturing. I can't recall the cost to produce a device however I have a guess and say $200. With $8m you could produce 40,000~ devices.
Why would you need/ forecast to produce anywhere near this many devices without a significant PO?
There HAS to be something in the pipeline. It doesn't make any sense otherwise. It's not like we're talking about manufacturing 1000 devices. We're talking 10's of thousands...
Can anyone recall the manufacture price?
- Forums
- ASX - By Stock
- GMV
- Ann: Notice of Annual General Meeting
Ann: Notice of Annual General Meeting, page-27
-
-
- There are more pages in this discussion • 426 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online